News

Search:
 Search

Latest News | 14 August 2012

FDA Calls for Evaluation of Suicidal Ideas and Behavior in all CNS Drug Trials

0 Likes

A new draft guidance released by the US Food and Drug Administration (FDA) addresses suicidal thoughts and behavior occurring in clinical trials and how to proactively assess the risks during drug Read More...


RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

New Regulatory Focus Apps for iPad and iPhone